A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was whether performing microwave ablative procedures during concomitant cardiac surgical procedures is effective for the treatment of atrial fibrillation (AF). In total, 200 papers were found using the reported search, of which 12 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Major exclusion criteria included studies exclusively using bipolar ablation, ambiguous or unspecified ablation technique, other energy modalities and studies with highly variable or undisclosed follow-up time. One study reported that 66% of patients were in sinus rhythm (SR) with follow-ups ranging from 1 to 14 months and suggested that the risk of AF recurrence was significantly increased with a larger left atrial diameter (OR = 1.21, P = 0.02) and an increased duration of preoperative AF (OR = 2.14, P = 0.03). A separate study found no significant difference in the success rate on the basis of the concomitant procedure (coronary artery bypass grafting or mitral valve surgery, P > 0.5). In the only randomized trial identified, microwave ablation delivered significantly inferior SR restoration rates to radiofrequency (RF) ablation at all time points from discharge to 24 months. There is a large degree of heterogeneity in the studies, with patients' characteristics, for example type of AF, and patient management postoperatively, for example administration of anti-arrhythmias, being inconsistent. Of the 12 studies, nine assessed SR at a mean of 6-12 months and found postoperative success rates between 62 and 87%. One study looked at the medium range follow-up of 24 months with SR restoration at 71%. Two studies looked at the long-term follow-up (5 and 5.37 years) with SR restoration at 39 and 61%, respectively. We conclude that microwave ablation, as an intervention for the treatment of AF during concomitant surgery, is not currently recommended on the limited available evidence. This is because the success rates in the longer term are less clear and the only randomized study to date has found inferior outcomes compared with RF-based ablation.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION
In [ patients undergoing concomitant cardiac surgery for atrial fibrillation (AF)] is [microwave ablation] compared to [no treatment, catheter based therapy, or other sources of energy] an effective procedure for returning the patient to [sinus rhythm (SR)].
CLINICAL SCENARIO
You have under your care a 58-year old patient with mitral regurgitation and paroxysmal AF. You would like to treat his AF during the procedure. You usually use a radiofrequency (RF) bipolar device to perform pulmonary vein isolation, but a colleague has a new microwave ablation device available today that you could use. You resolve to check from the literature that the results are broadly comparable to your usual method prior to embarking on using this device. 
SEARCH STRATEGY
Medline
SEARCH OUTCOME
Two hundred papers were found using the reported Medline search. Major exclusion criteria included studies using only other energy modalities (such as RF or cryoablation), studies where the ablation technique was ambiguous or not directly specified and papers with highly variable or undisclosed follow-up time. Specifically, papers with <20 patients and <6 months mean follow-up were also excluded. From the search, 11 papers were identified that provided evidence addressing the specific question. These are presented in Table 1 .
RESULTS
Paucity of level 1 evidence (only one randomized trial [2] identified) was a major limitation to this analysis and many of the studies share similar methodological flaws. In several, patients were given anti-arrhythmic medication or were cardioverted during follow-up, making it difficult to determine whether microwave ablation had cured AF [2] [3] [4] [5] [6] [7] [8] . Evaluation of SR restoration was through 24-72 h Holter electrocardiogram monitoring at outpatient clinics. This method can miss recurrent or asymptomatic AF, as patients were not monitored continuously throughout the follow-up period. Some studies also included patient populations with a mixture of permanent and paroxysmal AF [3, 9, 10] . Furthermore, the follow-up time and preoperative AF duration of patients in many of the studies were often very variable. Maessen et al. [3] reported that 87% of patients were in SR at a mean period of 6.4 months postoperation in a study of 24 patients. Wisser et al. [11] reported that 81% of the patients were free of AF at 12 months in a study of 23 patients, concluding that microwave ablation gave similar results to RF ablation.
Kabbani et al. [4] reported that 74% of the patients were in SR at 6 months in a study of 84 patients. Additionally, preoperative left atrial diameter (LAD) seemed to be an important factor in the conversion to SR, with a mean diameter of 7.0 cm in nonresponding patients compared with 5.7 cm in responding patients (P < 0.001).
Ahlsson et al. [9] reported that 74% of the patients were in SR at 12 months in a study of 20 patients. They also noted that all patients in SR at 6 months postoperatively displayed left and right A waves of equivalent velocity to those seen in patients in SR preoperatively. Thus, they suggest that microwave ablation can restore SR in a majority of patients while also preserving atrial mechanical function. Topkara et al. [10] reported that 67% of the patients were in SR at 1-year in a study of 85 patients. However, the mean follow-up was only 0.8 ± 0.6 years.
Knaut et al. [5] reported that 72% of the 42 patients who underwent microwave ablation concomitant to isolated coronary artery bypass graft (CABG) were in SR at 12 months, compared with 63% of the 68 patients who underwent microwave ablation concomitant to isolated mitral valve surgery. They concluded that microwave ablation in combination with CABG or mitral valve surgery can be performed with comparable success rates.
Zembala et al. [6] reported 66% of the 42 patients in SR at a mean period of 7.3 months postoperatively and suggested that the risk of AF recurrence was significantly increased with a larger LAD (OR = 1.21, P = 0.02) and an increased duration of preoperative AF (OR = 2.14, P = 0.03).
Another study by Knaut et al. [7] reported 65% of the patients in SR at 1-year in a study of 96 patients. They also examined success rates between patients undergoing the ablation by two different techniques (described in Table 1) , and between patients undergoing ablation with CABG alone, or CABG in combination with other procedures. They found a significant difference in success rates between CABG combined with the initial technique or combined with the box technique (52 vs. 74%, respectively, P = 0.0026).
Knaut et al. [8] published a further study showing 62% of the patients in SR at 1-year in a study of 202 patients, although many of these patients were lost during follow-up. The paper does not suggest why the attrition rate was so high. The Knaut group has published several papers investigating different factors affecting the rate of sinus conversion after microwave ablation. It is important to note that it is unclear whether the patients used for their studies overlap.
Over the longer time periods of 3 and 5 years, Kim et al. [12] demonstrated an 80% and a 61% freedom from AF, respectively (without anti-arrhythmic administration). Vicol et al. [13] showed that at a mean period of 5.37 years, only 39% of the patients who underwent ablation were in SR, a vastly lower proportion than noted in other studies assessing SR over shorter periods of time. They therefore concluded that microwave ablation is not a reliable method of achieving long-term conversion to SR.
Lin et al. [2] conducted a prospective trial in which patients were randomized to either undergo microwave (n = 94) or RF (n = 93) ablation. At all follow-up time points ranging from discharge to 24 months, there was a significant difference in the numbers of patients remaining in SR that favoured RF over MW ablation. The authors stated that the MW antenna in particular had to be repositioned two to three times to finish the circular lesion around the endocardial pulmonary veins. They postulated that the uncertainty in transmurality and continuity of the lesions might have contributed to the inferior success rates of MW relative to RF ablation.
